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ABSTRACT
Important decisions concerning heart health treatments are based on blood pressure measurements, as they are a valued vital
indicator by all medical professionals. The criteria that healthcare professionals use to assess blood pressure tightened in 2017, but
the equipment necessary to evaluate blood pressure at the new standard has not improved [1]. Current methods produce readings
that are often not trusted by medical professionals due to a lack of accuracy and consistency found in the devices’ technologies
and methods. These devices are also uncomfortable for the patient. The purpose of this project was to answer unmet needs of the
healthcare industry with a new blood pressure measuring device. The device was designed to measure a patient’s blood pressure at
the superficial temporal artery by detecting the artery’s Korotkoff waveform, which is heard following the release of arterial
constriction. The development of the device followed the Food and Drug Administration's (FDA) medical device design controls
waterfall diagram through The University of Akron’s Biomedical Engineering Senior Design course. The work was divided into
five gates including: User Needs, Design Input, Design Process, Design Output, and Medical Device. The result of the project was
a concrete proof of concept prototype that proved design refinement and business continuation are feasible.
1

Department of Biomedical Engineering, The University of Akron, Akron, OH
TABLE OF CONTENTS
Introduction ....................................................................... 1
Design Requirements ........................................................ 2
Approach ............................................................................ 2
Final Implementation & Deliverables.............................. 3
Performance Test Results ................................................. 3
Progress .............................................................................. 3
Individual Contributions .................................................. 3
Financial Considerations .................................................. 4
Summary Feasibility Discussion ...................................... 4
Future Work ...................................................................... 4
Discussions, Lessons Learned & Conclusions ................. 5
Acknowledgements ............................................................ 5
References .......................................................................... 5
Appendix ............................................................................ 7

I. INTRODUCTION
Device development originated with the 2019 Biomedical
Engineering Society (BMES) Coulter College program hosted
by Medtronic. The team was originally assigned the problem,
“compliance to the prescribed medication regimen is an issue
for patients with mild-to-moderate hypertension”. In
preparation for the program, the team researched the problem
and identified a clinical need for a new blood pressure monitor.
This idea was then transformed into a senior design project and
the team referred to themselves as the “Cardiovascular
Conquerors.” High blood pressure, or hypertension, is
detrimental to heart health over time and is defined as blood
pressure at or greater than 130/80mmHg [1]. Hypertension is a
growing global issue and continues to affect hundreds of
millions of people every year [2]. The World Health
Organization (WHO) has estimated that about 40% of the
global population suffers from hypertension [2]. At the
culmination of the program, the team travelled to Minneapolis
where they learned important lessons about customer needs,
design, development, and marketing, as well as planning for

potential business ventures. Following this event, the team
decided to continue working on this concept as their senior
design capstone project.
Research into the clinical setting revealed that the standard
process for clinicians to diagnose hypertension is long and
tedious [3]. Furthermore, the blood pressure recorded during an
office visit is oftentimes inaccurate, leading to misdiagnosis
and inadequate treatment. Since hypertension and its treatment
protocols are so reliant on device accuracy, a new type of blood
pressure monitor must be developed.
There are several automatic and manual devices currently
on the market that record blood pressure. A commonly used
automatic blood pressure monitor is the Dinamap by General
Electric (GE). While automatic cuffs provide convenience to
hospital staff, there is a problem with the devices’ accuracy,
placement, and comfort [3]. The team consulted several nurses,
with backgrounds in dialysis, Intensive Care Unit (ICU),
outpatient, and trauma [3]. From these interviews, it became
apparent that blood pressure cuffs are often misplaced because
of the locational variation permitted and minimal locating
assistance. Improper placement of a cuff on a patient’s arm can
lead to an inaccurate measurement [3]. Traditionally, the arm is
the primary location for cuff placement, but it can be difficult
to access depending on patients’ other medical situations.
Circumstances may include cancer patients in which arm
restriction could be detrimental to lymph node health [3].
Additionally, patients with an IV or another similar device in
their arm can restrict the use of cuffs [3]. The arterial
constricting cuffs are also uncomfortable for patients. The team
planned to eliminate the requirement for medical professionals
to consistently place the device on the arm by using a unique
and more intuitive location.
The traditional blood pressure cuff, which utilizes a manual
sphygmomanometer and stethoscope, is the most commonly
used device in clinical settings. It is considered the gold
standard of blood pressure monitoring [4]. These devices
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provide an affordable alternative but, like the automatic cuffs,
rely on adequate training and proper placement to obtain an
accurate measurement. Additionally, manual cuffs require the
operator to correctly listen to the sounds obtained during a
blood pressure recording, which is the main source of error.
This basic skill of taking a manual blood pressure is often
glossed over by trainees because of its simplicity according to
a source from the Northeast Ohio Medical University
(NEOMED) [3]. These trainees also often overlook the
importance of placing the center of the cuff bladder directly
over the brachial artery [3]. This is a critical step in the
preparation for recording blood pressure and if the artery does
not receive the necessary direct pressure, the reading can be
inaccurate leading to mistreatment. Alternatively, the arterial
catheter is commonly used in the ICU to obtain a direct blood
pressure measurement. While this device is the most accurate
option, it is the most invasive and uncomfortable for the patient.
There is a clear need for a device that is accurate, non-invasive,
and subject to less user error than traditional devices. Therefore,
the team’s requirements consisted of affordability, comfort,
ease of use, consistency, non-invasiveness, and accuracy of
readings to the end user.
II. DESIGN REQUIREMENTS
In the first gate, user needs, the design requirements were
prepared through a series of interviews from nurses, nurse
managers, and cardiologists. These interviews allowed the team
to understand the user needs for the new device. As the team
continues to obtain interviews from various professionals, they
validate and iterate on the user needs that were originally
established in the beginning of the design. An example of a user
need was for the device to take non-invasive measurements as
fast or faster than similar devices. Additionally, the device
should be comfortable for the patient in regard to size and
weight. Most importantly, the device must accurately and
precisely output readings comparable to or better than the
current gold standard. After this information was compiled, a
list of customer requirements was made and can be found in
Table 1 in the Appendix.
Once the user needs were established, each customer
requirement was assigned a quantitative or qualitative
engineering requirement in gate two, design input. Engineering
requirements categorized as quantitative were assigned a
numerical target. For example, in order for the Cardiovascular
Conquerors’ device to be competitive against current devices, a
measurement processing time of less than or equal to 30
seconds was specified. Engineering requirements categorized
as qualitative and were assigned a Code of Federal Regulations
(CFR) section number, American Society for Testing and
Materials (ASTM) standard, or International Organization for
Standardization (ISO) standard. For example, one of the
customer requirements specified non-invasiveness. Therefore,
the team applied the necessary design controls listed in the CFR
Title 21, Chapter I, Subchapter H, Part 870, Subpart B, Section
870.1130 Noninvasive blood pressure measurement system [5].
A comprehensive list of the engineering requirements along

with specifications and metrics can be found in Tables 2 and 3
in the Appendix.
III. APPROACH
The team conducted a five-step process to reach a final
design output in the third gate, design process. This involved
the following steps: concept generation, primary & secondary
down-selections, benchtop testing, and a design Failure Mode
and Effects Analysis (FMEA). The major aspects requiring
determination were the anatomical location, the acquisition
method, and the system layout. The first part of concept
generation was a series of brainstorming techniques conducted
to determine the best and most reliable location for monitoring.
The second part of concept generation involved sensor research
including strain gauges, ultrasound, and optical sensors. The
team conducted preliminary down-selection through discussion
and decision matrices to reach solutions that were feasible
under the course’s time and resource constraints.
The resulting location was the superficial temporal artery
located directly in front of the ear. This artery is easily
accessible on the majority of hospitalized patients and is novel
to the effect that no other blood pressure monitoring devices in
the market take measurements on this artery. At this location,
the superficial artery can be located using the unique
geometries of the ear. This is an improvement beyond the
brachial artery in the arm and an opportunity for universal
sizing. In regard to sensors, the two most feasible routes, given
the team’s skill set, were strain gauges and optical sensors. This
led the team to pursue displacement sensors (microphone and
piezoelectric) and photoplethysmogram (PPG) sensors.
Following down selection, two benchtop testing paths were
pursued to determine the blood pressure measurement method.
The first path was the Absolute Obstruction Method (AOM)
without a circumferential cuff that utilized a microphone sensor
to detect a patient’s Korotkoff waveform. The Korotkoff
waveform is a series of blood turbulence heard by
sphygmomanometer users and generated by the constriction of
blood flow within an artery [6]. Blood pressure is derived from
the waveform. The second path was the derived PPG method
that utilized a PPG sensor coupled with an electrocardiogram
sensor to detect the changes in blood flow which leads to the
calculation of blood pressure. After the conclusion of tests and
the finalization of reports, a secondary down-selection was
conducted through a pros and cons list. With this in
consideration and to achieve the lowest inherent design risk
from the dFMEA, the AOM was concluded to be the primary
concept and the derived PPG method was the secondary
concept.
Next, the team sought advice from its mentor, Dr. Paul
Lecat a Professor of Internal Medicine, Pediatrics, and Family
Medicine at Northeast Ohio Medical University (NEOMED),
regarding the system layout. He suggested the device to have a
singular housing unit that could fit in the palm of a hand [7].
With all of these decisions made, the team confidently designed
the proof of concept prototype that could be tested and iterated.
A piezoelectric microphone was selected to sense Korotkoff
waves from arterial obstruction. This piezoelectric sensor
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would be situated near a small inflatable bladder to obstruct
blood flow in the superficial temporal artery. Originally, the
intent was to incorporate an automated bladder inflation
system, but due to time constraints and the loud sound produced
by low cost air pumps, it was replaced with a manual pump.
IV. FINAL IMPLEMENTATION & DELIVERABLES
The final objective was to design the entire remote
monitoring blood pressure device in the fourth and fifth gates,
design output and medical device, respectively. To achieve
success against competitive devices, the device was designed to
take accurate and precise measurements with a reasonable
processing time. Additionally, the design needed to be an
improvement upon existing devices by accommodating for
varying patient sizes, decreasing discomfort caused by
traditional cuffs and increasing portability. The device was also
designed to offer continuous monitoring. This design would be
benchtop tested to prove that the concept is feasible.
The resulting final device included a piezoelectric
microphone encased in a 3D printed housing with a balloon that
was manually inflated via a blood pressure bulb, equipped with
a release valve. The microphone was located distal to the
balloon in the housing. The pressure was monitored with a
pressure gauge, to regulate release rate, and pressure sensor, to
record and output the pressure reading to MATLAB. The
microphone and pressure sensor were controlled by a National
Instruments myDAQ that interfaced with a desktop computer
through MATLAB. A MATLAB code was utilized to power
components, filter signals, and process signals for the desired
output. A block diagram depicting the final component
interactions is found in Figure 1 of the Appendix.
V. PERFORMANCE TEST RESULTS
Proof of concept testing was completed during the assembly
of the device that allowed the team to evaluate the feasibility of
the Korotkoff waveform acquisition from the superficial
temporal artery. The overall desired output from the device was
a Korotkoff waveform when utilizing the AOM. A sample
waveform seen in Figure 2 in the Appendix shows the first and
last detected Korotkoff signal. This information was derived
from a previous study on the Korotkoff waveform [8]. The
pressure experienced by the artery at two points of arterial
constriction are interpreted as the systolic and diastolic
pressure.
The proof of concept testing achieved a Korotkoff
waveform with the prototype as seen in Figures 3 and 4 of the
Appendix. Figure 3 shows the Korotkoff waveform recorded
with pressure using a user’s finger while Figure 4 shows the
waveform obtained from the device’s balloon and housing.
Figure 3 showed a more distinct waveform with a prominent
peak and more noise in the signal. However, Figure 4 showed
more pressure control because of the gradual decrease of the
waveform following the pressure release. Also, Figure 4
showed steady arterial pulse sensed by the microphone because
of the repeated cyclic pattern observed during the period of
pressure release. Figure 4 was also a realistic representation of
the capabilities of the device as a whole, which revealed room
for improvement. To achieve the ideal waveform, the housing

and pressure system unit need to apply consistent pressure to
the ear. The balloon used in this testing did not apply enough
pressure to cut off circulation, so the user had to initially
accommodate and apply their own pressure skewing the results
and producing a waveform that was symmetric.
Once the concept was proven to be feasible, a competitive
analysis was performed on the device in comparison to the GE
Dinamap automatic cuff and the Welch Allyn DuraShock
Aneroid Sphygmomanometer [9], [10]. For the analysis, a one
denoted the lowest rank and a three denoted the highest rank.
The factors were assigned weights based off of customer
feedback of importance level. Many of the factors in the matrix
have not been validated yet, however, the metrics included are
indicators of where the team foresees the device once fully
developed. The competitive matrix can be found in Table 4 of
the Appendix. The matrix displays the novel device yielding the
greatest score overall with respect to the requirements and the
assigned weights.
VI. PROGRESS
Not all design specifications were implemented in the proof
of concept device because specifications such as fluid
resistance, wire exposure, battery life, and weight could not be
obtained while the device was attached to a prototyping board.
These specifications should still be implemented in the final
device even though they could not be accomplished with the
proof of concept prototype. Other specifications, such as
measurement processing time, accuracy, and precision could be
accomplished with the current device following further
refinement of the components.
Additionally, some specifications do not lend themselves to
testing in the classroom setting. For example, the requirement
of low training time will depend on data collected during
clinical trials. These trials cannot be completed during the
course or with a proof of concept prototype. However, they
should be included in the final device design.
Finally, the original specification for graphical and single
point reading outputs may be excluded or significantly altered.
Upon further market and customer research, it was apparent to
the team that different clinical settings require different types
of readings. For example, a nurse in the cardiac care unit in a
hospital was more interested in trends, whereas a dental
assistant was more interested in a one-time measurement, prior
to a procedure [3]. With more research into the market need,
this requirement must be adjusted to fit the needs of the
identified target market.
VII. INDIVIDUAL CONTRIBUTIONS
All students on the team had a shared responsibility for the
technical development of the medical device and roles were
assigned based on individual strengths and weaknesses. All
team members were the project manager for one of the five
gates, shared research work, brainstormed together, and
performed several interviews independently.
Alison was responsible for the group finances, so she
purchased all the device components and managed the project’s
budget and funds. She also coordinated outside business
ventures and was the primary point of contact with one of the

Pg. 3 of 9

Biomedical Engineering Design
4800:491/492
team’s mentors, Dr. Lecat. She led the team’s development of
verification and validation test plans and procedures.
Allie researched reimbursement strategies for the team,
which included insurance codes and hospital billing
procedures. She also had the responsibility of designing
components that would be 3D printed for the team, including
the balloon housing and tubing converters. She led the team
through the I-CorpsTM program as the Entrepreneurial Lead to
obtain business knowledge for a potential start-up.
Arael was responsible for conducting the physiological
research. She helped create risk management documents and
made notable progress in the investigation and testing of the
secondary design option, PPG. Also, she wrote the foundation
of the code used to process and analyze Korotkoff wave inputs.
Jillian was responsible for technical and market research.
She managed document control for the team and ensured the
design history file was properly organized. She was the
technical leader in the device’s assembly and development. She
experimented with different microphone sensors and
processing capabilities in benchtop testing.
Megan was the leader in researching the current competing
products on the market and performed the quality function
deployment to begin the device development. She did all of the
device drawings in SolidWorks. She also led the decisionmaking process for component selection and assisted in
document organization.
VIII. FINANCIAL CONSIDERATIONS
The University of Akron department of Biomedical
Engineering allocated $500 for the team to utilize in the device
design and development. Due to the need for advanced
components, the Cardiovascular Conquerors applied for outside
grants, participated in The University of Akron Research
Foundation (UARF) I-Corps Program, and requested financial
support from The University of Akron Williams Honors
College. These additional sources of funding allowed for the
device to be developed to the team’s best ability.
For the device prototype, the value of all components was
$874.12. However, some components in the design were lent to
the team by the university and others were used for secondary
design approaches. The total cost for the proof of concept
prototype parts was $387.16. The full breakdown of the Proof
of Concept Bill of Materials (BOM) can be seen in Table 5 of
the Appendix.
The prices vary for products currently sold on the market.
Simple, hand-held cuffs are sold for roughly $50, while more
complex devices such as arterial tonometers are sold for
$2,000[11], [12]. The target price for the product would be
$500 [11], [12], [13]. The BOM shows a much greater total cost
for components, but with continued development and bulk
purchasing, the team believes that they can produce a device in
that price range. While it is more expensive than similar
products on the market, the measurement accuracy is much
greater and will require more expensive development methods
and components. Furthermore, the increased accuracy will
persuade buyers to invest in a higher quality product, especially
in the hospital setting.

With further development of the project, the team
anticipates additional cost expenditures. For example, if a
patent is pursued, funding will need to be allocated.
Additionally, external services, including testing resources and
industrial designers would be required for a finished product to
be achieved. These resources are advantageous as they will aid
in completion of design verification and device design
refinement, respectively. Components with refined capabilities
will need to be purchased throughout the development process,
which will incur more costs to the team.
IX. SUMMARY FEASIBILITY DISCUSSION
At the beginning of the project, the need for a remote,
accurate, and reproducible blood pressure monitor was
identified. The team followed the necessary design process to
meet the specified need and accomplished promising results
that confirmed the device was capable of collecting the desired
signal. However, due to the complexity and restrained timeline
of the project, it was uncertain whether the team’s model could
measure and record a blood pressure reading to the degree of
accuracy and precision needed.
The Cardiovascular Conquerors product was considered a
proof of concept design because some of the critical design
features perform as intended [14]. The team is in the process of
verifying the MATLAB code that acquires the signal and
calculates the blood pressure reading. The device’s ability to
meet engineering requirements and customer needs will be
evaluated in future verification and validation testing.
X. FUTURE WORK
Due to The University of Akron campus shut down because
of the COVID-19 virus, the prototype phase was halted
abruptly. The team recommends that the next step for the
project is to continue research on the market need in order to
refine its design to the needs of potential purchasers. The team
has already begun this process through participation in the ICorps training program through UARF. The Cardiovascular
Conquerors are also preparing to apply to multiple design
competitions that should provide more resources for the
advancement of the device and future business.
The proof of concept device will need to be further
developed to show that applying pressure without a
circumferential cuff and obtaining Korotkoff waveforms is
feasible. Once the technique is feasible and there is an
established market for the device, it will be refined for this entry
market.
Future work includes improving the individual components
to support a hands-free device. For example, including an
electric pump so the inflation and deflation of the balloon is not
reliant on the operator will increase repeatability, thus reducing
risk and human error. Additionally, the team will add locating
features to assist placing the device correctly on the patient. The
team will also work on the user interface, so it meets the needs
of the customer. This may include trendlines, alert systems, etc.,
depending on what the clients in the target market require.
Based on how easily the device could be used properly at home,
there is a potential that an app could be further developed. This

Pg. 4 of 9

Biomedical Engineering Design
4800:491/492
would allow the device to provide support in the telemedicine
business sector.
Once the design is finalized, the device’s ability to meet
user needs and engineering requirements must be assessed in
validation and verification tests respectively, further explained
in Table 6 and Table 7 in the Appendix. This includes analyzing
requirements such as accuracy/precision, weight, and
measurement processing time through verification then comfort
and non-invasiveness through validation.
XI. DISCUSSION, LESSONS LEARNED, &
CONCLUSIONS
One issue that arose during the development process were
the connections required for each of the components that the
design team purchased. The Cardiovascular Conquerors
identified the need for a release valve in the BOM but did not
appropriately account for the ability of the valve to steadily
release air at the low rate specified by the AHA. It was difficult
for the team to find an automated release valve that met the
identified specification. This led to a prolonged development
time as the appropriate component was acquired. The team
utilized a manual release valve for the time being as it met the
specification appropriately and it was easily accessible.
The senior design course was split into five “stage gates”
that followed the FDA waterfall process from user needs to
medical device. However, due to the COVID-19 outbreak, the
course was modified, thus the team was only required to get
through gate 4, the design output stage. As an alternative to the
originally planned gate 5 activities, the team continued to
perform customer interviews and solidify their business model,
since they plan to continue developing the device upon
graduation.
Throughout the course of the semester, the Cardiovascular
Conquerors met twice per week to ensure development
milestones were accomplished according to the course
schedule. With the stage gate requirements, it was pertinent that
any issues regarding assigned tasks were addressed
immediately when they arose. All tasks were distributed evenly
across its members and assigned according to each individual's
strengths. Additionally, each team member had the opportunity
to be the project manager for a stage gate. At the culmination
of each required stage gate, feedback and guidance was
obtained from the course mentors, Dr. Keszenheimer and Dr.
Alhalawani. Their feedback was useful in making necessary
adjustments to the project.
The senior design course provided deadlines and
deliverables for the team to meet over the course curriculum. In
the future, requirements for the entire course should be
provided to students so the team can make an effort to work
ahead and ensure they stay on track. Since the senior design
course is over the duration of eight months, the team attempted
to get as far in the development process as possible with the
allotted amount of time. That being said, the Cardiovascular
Conquerors made significant progress and are excited to
continue working towards better blood pressure management.
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XIV. APPENDIX

Figure 1. Overall Block Diagram

Figure 4. Korotkoff Waveform with Air Pressure and Housing
Table 1. Customer Requirements
Accurate & Precise
Fast
Non-Invasive
Continuous Monitoring
Adaptive to Patient
Reliable Power
Comfortable
Infrequency Calibration
Data Integrity
Compatible with Hospital Setting
Remote Monitoring
Easy to Transport
Intuitive
Affordable
Cleanliness

Figure 2. An Ideal Korotkoff Waveform Achieved with Arterial
Obstruction by a Cuff

Figure 3. Korotkoff Waveform with Finger Pressure

Table 2. Qualitative Engineering Requirements
Qualitative Requirement
Applicable Standard
Noninvasive
Code of Federal Regulations
(CFR) Title 21- Food and Drugs,
Chapter I, Subchapter H, Part
870, Subpart B, Section
870:1130 Noninvasive Blood
Pressure Measurement System
Secure Data
HIPPA Privacy Rule 45 CFR
Part 160 and Subparts A and E
of Part 164
Wire Exposure
IEC 60601-1 Medical Electrical
Equipment: General
Requirements for Basic Safety
and Essential Performance
Fluid Resistance
ASTM F146 – 12(2019)
Biocompatibility
ISO 10993-1:2018 Biological
Evaluation of Medical Devices
Insurance Coverage
A4670 Automatic Blood
Pressure Monitor
Remote Monitoring
ANSI C63.27/D1.0 Standard for
Evaluation of Wireless
Coexistence (2017)
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Table 3. Quantitative Engineering Requirements
Quantitative Requirement
Target
Measurement Processing Time
≤ 30 seconds
Adjustable Sizing
≥ 90% of patients
Accuracy
± 3 mm Hg
Precision
± 3 mm Hg
Radio Frequency Interface
1.705-80 MHz
Operating Temperature
50-104 ̊ F
Audible Sound (Pitch)
≤ 50 dB
Power Source
≥ 1 source
Weight
≤ 2 pounds
Battery Life
8 hours
Cost
≤ $200.00
Training Time
30 minutes
Maintenance Interval
≥ 6 months

Table 5. Proof of Concept Bill of Materials (BOM)

Table 4. Competitive Matrix
Competitive Matrix
Factors

Weight

General Electric
Carescape V100
(Dinamap)

Welch Allyn
DuraShock Aneroid
Sphygmomanometer

Rating
(1-3)

Rating
(1-3)

Score

Score

Part Name

Part Name from Manufacturer
Website

Actual
Cost

Cost to
Team

Balloon

Disposable NIBP Cuff M1868A

$22.00

$22.00

Pressure Sensor

Amphenol Advanced Pressure
Sensor

$30.44

$30.44

Microphone

TE Connectivity Microphone

$43.44

$43.44

Pressure Gauge

N/A

$0.00

$0.00

Tubing

Soft Plastic Tubing for Air and
Water, 3 mm ID

$8.50

$8.50

Pressure Sensor
Board Adapter

Sockets & Adapters SO Prototyp
Adaptor 14 contact SOIC

$4.10

$4.10

Tubing Converter

N/A

$0.00

$0.00

Balloon Housing

N/A

$0.00

$0.00

5 Ω Resistor

N/A

$0.02

$0.00

Operational
Amplifier

AD620 Instrumentation
Amplifier

$5.80

$0.00

0.1 uF capacitor

N/A

$0.41

$0.00

$7.35

$0.00

Novel Device
Rating
(1-3)

Score

Adjustable
Sizing

0.20

2

0.40

2

0.40

3

0.60

Manual Air Pump

Welch Allyn Tycos Premium
Inflation Bulb

Cost

0.15

1

0.15

3

0.45

2

0.30

N/A

$0.86

$0.00

Accuracy

0.10

2

0.20

3

0.30

3

0.30

Braided Shielded
26 Gauge 3
Conductor Cable

Maintenance
Interval

0.10

2

0.20

3

0.30

1

0.10

Colored Wire

Multi-Colored 5-inch Jumper
Wire Kit

$4.75

$0.00

Measurement
Processing
Time

0.10

2

0.20

1

0.10

3

0.30

Precision

0.10

1

0.10

2

0.20

3

0.30

Remote
Monitoring

0.10

2

0.20

1

0.10

3

0.30

Battery Life

0.09

1

0.09

3

0.27

2

0.18

Training
Time

0.06

3

0.18

2

0.12

3

0.18

Total

1.72

2.24

NI myDAQ

NI myDAQ

$371.00

$0.00

Microphone
Housing

N/A

$0.00

$0.00

Manual Air Pump
Release Valve

N/A

$32.45

$0.00

NI myProto

NI myProto

$343.00

$0.00

Blood Pressure
Bulb Tubing

N/A

$0.00

$0.00

$874.12

$108.48

2.56
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Table 6. Verification Testing Table
Test Name

Engineering
Requirement
#

Measurement
Processing
Time

1.1.2

Weight

1.2.1

1.3.1.1

Accuracy and
Precision

1.3.2.1

Design
Input

Acceptance
Criteria

Verification
Protocol
Document

Sample
Type

The device
must take
incremental
measureme
nts during a
specific
period of
time.
The device
should be
comfortable
to the
patient, in
regard to
size and
weight,
comparable
to other
similar
devices.
The device
must
accurately
output
readings
comparable
to or better
than the
current gold
standard.
The device
must
precisely
output
readings,
regardless
of user,
comparable
to or better
than the
current gold
standard.
(repeatable)

The blood
pressure
measurements
are both
processed and
displayed at or
under 30
seconds.

1204.00

Alpha

The device
should be less
than or equal to
2 pounds.

1203.00

Beta

1202.00

Alpha

1202.00

Alpha

The difference
between the
blood pressure
recordings on
the calibrated
sphygmomano
meter and
device is at or
less than
3mmHg.

Table 7. Validation Testing Table
Test Name

Requirement
Type &
Project
Reference

Requirement
Description

Acceptance
Criteria

Validation
Protocol
Document

NonInvasive

Customer
Req. 1.1.3

The device
must take noninvasive
measurements.

The device
should not
break the
skin barrier
for all users.

1302.00

Customer
Req. 1.2.1

The device
should be
comfortable to
the patient, in
regard to size
and weight,
comparable to
other similar
devices.

The device
should be
rated
comfortable
to 95% of
patients.

1303.00

Comfort
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